A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection
- PMID: 20861246
- PMCID: PMC2976401
- DOI: 10.1128/JVI.01633-10
A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection
Abstract
Herpes simplex virus (HSV) entry into cells is triggered by the binding of envelope glycoprotein D (gD) to a specific receptor, such as nectin-1 or herpesvirus entry mediator (HVEM), resulting in activation of the fusion effectors gB and gH and virus penetration. Here we report the identification of a hyperactive gB allele, D285N/A549T, selected by repeat passage of a gD mutant virus defective for nectin-1 binding through cells that express a gD-binding-impaired mutant nectin-1. The gB allele in a wild-type virus background enabled the use of other nectins as virus entry receptors. In addition, combination of the mutant allele with an epidermal growth factor receptor (EGFR)-retargeted gD gene yielded dramatically increased EGFR-specific virus entry compared to retargeted virus carrying wild-type gB. Entry of the gB mutant virus into nectin-1-bearing cells was markedly accelerated compared to that of wild-type virus, suggesting that the gB mutations affect a rate-limiting step in entry. Our observations indicate that ineffective gD activation can be complemented by hypersensitization of a downstream component of the entry cascade to gD signaling.
Figures






Similar articles
-
Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus.J Virol. 2016 Nov 28;90(24):11096-11105. doi: 10.1128/JVI.01456-16. Print 2016 Dec 15. J Virol. 2016. PMID: 27707922 Free PMC article.
-
Differential effects on cell fusion activity of mutations in herpes simplex virus 1 glycoprotein B (gB) dependent on whether a gD receptor or a gB receptor is overexpressed.J Virol. 2009 Aug;83(15):7384-90. doi: 10.1128/JVI.00087-09. Epub 2009 May 20. J Virol. 2009. PMID: 19457990 Free PMC article.
-
Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.J Virol. 2003 Sep;77(17):9221-31. doi: 10.1128/jvi.77.17.9221-9231.2003. J Virol. 2003. PMID: 12915538 Free PMC article.
-
Two Sides to Every Story: Herpes Simplex Type-1 Viral Glycoproteins gB, gD, gH/gL, gK, and Cellular Receptors Function as Key Players in Membrane Fusion.Viruses. 2021 Sep 16;13(9):1849. doi: 10.3390/v13091849. Viruses. 2021. PMID: 34578430 Free PMC article. Review.
-
Targeted entry of enveloped viruses: measles and herpes simplex virus I.Curr Opin Virol. 2012 Feb;2(1):43-9. doi: 10.1016/j.coviro.2011.12.002. Epub 2011 Dec 23. Curr Opin Virol. 2012. PMID: 22440965 Free PMC article. Review.
Cited by
-
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability.Mol Ther Oncolytics. 2020 Aug 8;18:476-490. doi: 10.1016/j.omto.2020.08.004. eCollection 2020 Sep 25. Mol Ther Oncolytics. 2020. PMID: 32953982 Free PMC article.
-
Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.J Virol. 2018 Aug 16;92(17):e00536-18. doi: 10.1128/JVI.00536-18. Print 2018 Sep 1. J Virol. 2018. PMID: 29950408 Free PMC article.
-
Oncolytic herpes simplex viruses designed for targeted treatment of EGFR-bearing tumors.Mol Ther Oncol. 2024 Jan 10;32(1):200761. doi: 10.1016/j.omton.2024.200761. eCollection 2024 Mar 21. Mol Ther Oncol. 2024. PMID: 38596286 Free PMC article.
-
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus.Mol Ther. 2013 Mar;21(3):561-9. doi: 10.1038/mt.2012.211. Epub 2012 Oct 16. Mol Ther. 2013. PMID: 23070115 Free PMC article.
-
Complete genome sequence of the first Chinese virulent infectious laryngotracheitis virus.PLoS One. 2013 Jul 29;8(7):e70154. doi: 10.1371/journal.pone.0070154. Print 2013. PLoS One. 2013. PMID: 23922947 Free PMC article.
References
-
- Anderson, D. B., S. Laquerre, K. Ghosh, H. P. Ghosh, W. F. Goins, J. B. Cohen, and J. C. Glorioso. 2000. Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry. J. Virol. 74:2481-2487. - PMC - PubMed
-
- Asano, R., Y. Sone, K. Makabe, K. Tsumoto, H. Hayashi, Y. Katayose, M. Unno, T. Kudo, and I. Kumagai. 2006. Humanization of the bispecific epidermal growth factor receptor x CD3 diabody and its efficacy as a potential clinical reagent. Clin. Cancer Res. 12:4036-4042. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous